stars 1 stars 2 stars 3

By coating any implant on the market with a bioactive nanolayer with a bone -strengthening drug, we know that millions of patients will experience better results and faster recovery. We call our product Zolidd®. Zolidd® has been evaluated in both pre-clinical and clinical studies, in both instances with excellent results. The landmark clinical results in the dental indication have generated serious interest from major companies. Clinical results showing significant benefits in orthopaedic indications will be of equal importance in discussions with leading orthopaedic implant partners who can benefit from differentiation and clinical development. AddBIO Gruppbild

AddBio AB Questions

The AddBio AB annual revenue was $1 million in 2026.

AddBio AB is based in Linkoping, OEstergoetland.

The NAICS codes for AddBio AB are [541, 54171, 541713, 54, 5417].

The SIC codes for AddBio AB are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users